Form 10-Q · Quarterly report
Solventum 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0001964738
- Accession no.
- 0001964738-26-000047
Summary
Solventum announced its intention to separate its Health Information Systems business and reported second-quarter 2026 net sales of $2.209 billion, up 2.2% year over year with 9.5% organic growth. The company also recognized a roughly $120 million receivable for IEEPA tariff refunds after the U.S. Supreme Court ruled the statute does not authorize presidential tariffs, and it completed the approximately $4 billion sale of its Purification and Filtration business to Thermo Fisher Scientific in September 2025.
Key points
- Solventum announced its intention to pursue a separation of its Health Information Systems business as part of its portfolio optimization strategy.
- Second-quarter 2026 net sales were $2.209 billion, up 2.2% reported and 9.5% organic, with organic growth led by MedSurg and Dental Solutions.
- Solventum submitted IEEPA tariff refund requests accepted by U.S. Customs and Border Protection totaling approximately $120 million including interest, and recognized a corresponding receivable as of June 30, 2026.
- Solventum completed the sale of its Purification and Filtration business to Thermo Fisher Scientific on September 1, 2025 for approximately $4 billion, after excluding its drinking water filtration business.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview Solventum is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise. Our 70+ year history of discovering and innovating advanced solutions has helped us solve our customers’ toughest challenges and become a trusted partner. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.